Call Now: +1 858 800 3101 Email:

Your shopping cart is empty!

RGD - targeted Proapoptotic Peptide

Product Code: 1258-005

Price: $316.00

Available Options

* Package Size:
- +
Description This sequence is a targeted proapoptotic peptide. The C-terminal RGD-4C peptide (ACDCRGDCFC) binds preferentially to integrins at sites of tumor angiogenesis. Two glycines provide spacer, and D(KLAKLAK)2 is the proapoptotic peptide composed of D-amino acids.
Sequence ACDCRGDCFC-GG-klaklakklaklak-NH2 (disulfide bridge: C1-C4 & C2-C3)
Sequence (3 Letter) H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-Gly-D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala-D-Lys-D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala-D-Lys-NH2 (S-S bonded C1-C4 & C2-C3)
Molecular Weight 2707.4
Purity > 95% By HPLC
Storage Store at -20 °C, cap vial tightly at all times.
Lahdenranta, J. et al. FASEB J. 10.1096/fj.07-8273com (2007); Ellerby, H. et al. Nat. Med. 5, 1032 (1999); Smolarczyk, R. et al. Acta Biochim. Pol. 53, 801 (2006); Curnis, F. et al. Cancer Res. 64, 565 (2004); Su, Z. et al. Bioconjug. Chem. 13, 561 (2002).

About InnoPep

InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.

Newsletter Signup

Stay Updated With Our Latest Products.

Your email is safe with us, we don't spam.